Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 17.40%853.55M | 7.05%745.05M | 69.88%1.09B | -38.05%2.73B | -34.23%666.11M | -17.64%727.04M | -28.42%696.01M | -58.35%640.62M | -6.11%4.41B | -9.20%1.01B |
| Net income from continuing operations | -46.39%190.41M | 100.54%514.59M | -13.15%212.68M | -27.18%1.26B | -41.81%407.45M | 29.31%355.19M | -49.75%256.6M | -2.18%244.87M | -61.31%1.74B | 2,405.87%700.2M |
| Operating gains losses | 118.54%27.84M | -4,098.00%-366.22M | 59.36%295.38M | -58.56%268.89M | 211.60%224.56M | -154.27%-150.19M | 110.54%9.16M | -71.93%185.36M | 130.26%648.84M | -118.55%-201.21M |
| Depreciation and amortization | 20.02%460.08M | 12.58%420.68M | 9.06%422.04M | 19.07%1.55B | 9.95%408.01M | 23.11%383.32M | 21.63%373.66M | 23.31%386.97M | 10.04%1.3B | 20.39%371.07M |
| Remuneration paid in stock | 14.65%17.98M | 4.36%17.54M | 10.14%17.07M | 26.96%63.86M | 43.93%15.87M | 30.44%15.68M | 22.16%16.81M | 14.87%15.5M | 75.07%50.3M | -8.90%11.03M |
| Deferred tax | -42.28%64.03M | 87.46%181.72M | -2.95%68.84M | -11.20%393.82M | -39.30%115.03M | 22.72%110.93M | 21.51%96.94M | -15.39%70.93M | -68.75%443.49M | 783.95%189.49M |
| Other non cashItems | -432.73%-24.64M | -56.76%454K | -69.37%-25.88M | -219.78%-313.57M | -224.23%-294.72M | -327.55%-4.63M | 78.88%1.05M | -56.18%-15.28M | 25.99%-98.06M | -18,028.60%-90.9M |
| Change In working capital | 182.08%115.94M | 53.58%-15.92M | -53.27%87.38M | -108.81%-27.12M | -976.91%-220.92M | 144.13%41.1M | -124.85%-34.29M | -21.30%186.99M | 251.44%307.66M | 108.54%25.19M |
| Dividends received (cash flow from operating activities) | -25.31%11.13M | -22.97%11.13M | -25.24%10.8M | -0.89%54.59M | -22.83%10.8M | 6.45%14.9M | 6.65%14.45M | 6.67%14.45M | 4.35%55.08M | 3.30%14M |
| Tax refund paid | 76.56%-9.2M | 50.66%-18.93M | --0 | -1,199.12%-526.77M | 100.56%34K | -646.23%-39.26M | -812.00%-38.37M | -1,694.62%-449.18M | ---40.55M | ---6.05M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 17.40%853.55M | 7.05%745.05M | 69.88%1.09B | -38.05%2.73B | -34.23%666.11M | -17.64%727.04M | -28.42%696.01M | -58.35%640.62M | -6.11%4.41B | -9.20%1.01B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -66.53%-692.37M | -55.94%-803.22M | -22.23%-714.08M | 37.03%-1.64B | 89.67%-123.55M | -30.29%-415.76M | 12.05%-515.08M | -16.47%-584.23M | -32.02%-2.6B | -118.06%-1.2B |
| Net PPE purchase and sale | -30.99%-774.04M | -71.79%-505.24M | -48.32%-825.02M | 8.29%-1.9B | 27.64%-460.19M | -4.50%-590.92M | -6.05%-294.11M | 6.43%-556.25M | -10.32%-2.07B | -25.69%-635.99M |
| Net business purchase and sale | ---- | ---- | ---- | 74.03%-169.04M | ---- | ---- | ---- | ---- | -860.58%-650.99M | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | --331.47M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | -53.38%81.66M | -34.85%-297.98M | 496.44%110.94M | -17.61%100.41M | 91.54%174.22M | -28.90%175.15M | 28.33%-220.98M | -130.12%-27.98M | 607.56%121.88M | 314.06%90.95M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -66.53%-692.37M | -55.94%-803.22M | -22.23%-714.08M | 37.03%-1.64B | 89.67%-123.55M | -30.29%-415.76M | 12.05%-515.08M | -16.47%-584.23M | -32.02%-2.6B | -118.06%-1.2B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 48.22%-161.17M | 132.15%58.17M | -563.67%-374.23M | 39.51%-1.09B | -579.36%-542.56M | 42.38%-311.28M | 59.77%-180.93M | 93.92%-56.39M | 33.73%-1.8B | 117.26%113.19M |
| Net issuance payments of debt | 1,144.63%164.33M | 326.79%377.3M | -138.29%-83.93M | -85.35%53.57M | -144.11%-238.28M | 88.77%-15.73M | -35.86%88.4M | 227.36%219.18M | 241.99%365.76M | 217.92%540.16M |
| Net common stock issuance | -16.68%3.38M | -71.97%5.39M | 394.69%27.84M | -28.22%41.19M | 1.02%12.28M | -85.70%4.06M | 106.25%19.21M | -25.14%5.63M | -69.68%57.37M | -40.11%12.16M |
| Cash dividends paid | -9.77%-328.89M | -12.47%-324.52M | -13.14%-318.14M | 46.75%-1.19B | 27.91%-316.56M | 30.08%-299.61M | 51.66%-288.55M | 63.11%-281.2M | 16.07%-2.23B | 48.08%-439.13M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 48.22%-161.17M | 132.15%58.17M | -563.67%-374.23M | 39.51%-1.09B | -579.36%-542.56M | 42.38%-311.28M | 59.77%-180.93M | 93.92%-56.39M | 33.73%-1.8B | 117.26%113.19M |
| Net cash flow | ||||||||||
| Beginning cash position | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -21.06%70.02M |
| End cash Position | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Free cash from | -95.25%6.44M | -31.92%239.09M | 232.51%262.27M | -79.76%470.63M | -125.19%-94.94M | -57.30%135.52M | -49.44%351.18M | -91.58%78.88M | -15.20%2.33B | -38.15%376.83M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.